Cita APA (7a ed.)
Kawai, S., Hasegawa, J., Ito, H., Fukuuchi, Y., Nakano, H., Ohtani, H., . . . Adachi, T. (2023). Efficacy and safety of twice‐daily tramadol hydrochloride bilayer sustained‐release tablets with an immediate release component for postherpetic neuralgia: Results of a Phase III, randomized, double‐blind, placebo‐controlled, treatment‐withdrawal study. Pain Practice, 23(3), 277-290.
Cita Chicago Style (17a ed.)
Kawai, Shinichi, Jun Hasegawa, Hideki Ito, Yasuo Fukuuchi, Hideshi Nakano, Hideaki Ohtani, Kazutaka Sasaki, y Takeshi Adachi. "Efficacy and Safety of Twice‐daily Tramadol Hydrochloride Bilayer Sustained‐release Tablets with an Immediate Release Component for Postherpetic Neuralgia: Results of a Phase III, Randomized, Double‐blind, Placebo‐controlled, Treatment‐withdrawal Study." Pain Practice 23, no. 3 (2023): 277-290.
Cita MLA (9a ed.)
Kawai, Shinichi, et al. "Efficacy and Safety of Twice‐daily Tramadol Hydrochloride Bilayer Sustained‐release Tablets with an Immediate Release Component for Postherpetic Neuralgia: Results of a Phase III, Randomized, Double‐blind, Placebo‐controlled, Treatment‐withdrawal Study." Pain Practice, vol. 23, no. 3, 2023, pp. 277-290.
Precaución: Estas citas no son 100% exactas.